Search Results
Active Filters
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Sep 18, 2025, 08:30 ET IceCure Granted Notice of Allowance for U.S. Patent for its Next-Generation XSense™ Cryoprobes
Sept. 18, 2025 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option
More news about: IceCure Medical
Sep 16, 2025, 12:29 ET Cancer Immunotherapy Surge Drives $258B Market as FDA Accelerates Approvals
developments position Oncolytics Biotech Inc. (NASDAQ: ONCY), Anixa Biosciences, Inc. (NASDAQ: ANIX), IceCure Medical Ltd. (NASDAQ: ICCM), ImmunityBio, Inc. (NASDAQ: IBRX), and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN).
More news about: USA News Group
Sep 15, 2025, 08:30 ET IceCure Receives Regulatory Approval in Israel for its Next-Generation XSense™ Cryoablation System for Breast Cancer and Other Indications
/PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option
More news about: IceCure Medical